Sherlock′s Diseases of the Liver and Biliary System 12th Edition
Author(s): James S. Dooley (Editor), Anna S. F. Lok (Editor), Jenny Heathcote (Editor)
Publisher: Wiley–Blackwell
Publication Date: 18 April 2011
Edition: 12th
Language: English
Print length: 792 pages
ISBN-10: 1405134895
ISBN-13: 9781405134897
Book Description
The review from Gastroenterology sums up the appeal of this book: “More than any other text in liver diseases, this one provides the best source of synthesised clinical wisdom, a currency in ever increasingly short supply as our fund of factual knowledge burgeons. Indeed, if one demanded that an author confine the breadth of our knowledge in liver disease into a readable clinical textbook of less than 700 pages, he or she could do no better than to direct that individual to Sherlock and Dooley′s Diseases of the Liver and Biliary System”.
Editorial Reviews
Review
“This is a concise, updated, and well–written book that justifies replacing the previous edition. It is definitively useful and exhibits the same high quality of other currently available books in hepatology. I know I will consult my copy on a frequent basis –– an unusual event in this era of online material.” (Doody′s, 16 March 2012)
“James Dooley is to be congratulated on his courage and dedication along with his clearly inspiring leadership to contributing authors has not allowed Sheila′s volume to die with her passing. The Hepatology world, has been given a thoroughly up–to–date, exciting and cleverly produced volume which competitors will have greatest difficulty in matching.” (Institute of Hepatology, 2011)
From the Back Cover
The review from Gastroenterology sums up the appeal of this book: “More than any other text in liver diseases, this one provides the best source of synthesised clinical wisdom, a currency in ever increasingly short supply as our fund of factual knowledge burgeons. Indeed, if one demanded that an author confine the breadth of our knowledge in liver disease into a readable clinical textbook of less than 700 pages, he or she could do no better than to direct that individual to Sherlock and Dooley’s Diseases of the Liver and Biliary System”.
About the Author
James Dooley, Editor-in-Chief, worked with Professor Dame Sheila Sherlock on this book for three editions before her death in December 2001. He is a Consultant Hepatologist at the Royal Free Hospital, London.
Andrew Burroughs is a Consultant Physician and Hepatologist at the Royal Free Hospital, Liver Transplantation and Hepato-biliary Medicine Unit. He qualified in Liverpool with a MB ChB Honours in 1976, gained his MRCP in 1978 and FRCP in 1991. He is a Fellow of the European Board of Gastroenterology. He has been Scientific Secretary of the European Association for the Study of the Liver 1997-1999. He continues his association with EASL as administrative secretary until 2001. He is a council member of the United European Gastroenterology Federation until 2002, and a council member of the International Association for the Study of the Liver. He is a member of the MRC advisory board in the UK, from 1997 onwards. He was a member of Council of the British Society of Gastroenterology from 1992 to 1995. Andrew Burroughs main research interests are portal hypertension, variceal bleeding and coagulopathy, primary biliary cirrhosis, prognosis in liver disease and liver transplantation. He has published over 200 peer-reviewed articles.
Anna Lok is a Professor of Internal Medicine and the Director of Clinical Hepatology at the University of Michigan Medical Center. Her research focuses on the epidemiology and treatment of hepatitis B and C viruses. Millions of people worldwide are infected and are at risk for hepatitis-associated cirrhosis and hepatocellular carcinoma. Dr. Lok has made seminal contributions to our understanding of the natural history of hepatitis B and the role of hepatitis B virus genotypes and variants in the outcome of chronic hepatitis B infection. She has also made contributions to the treatment of hepatitis-induced diseases. She is currently testing new antiviral therapies for hepatitis B, developing cost-effective methods for preventing recurrent hepatitis B infection following liver transplantation, and studying the long-term effects of interferon treatment in patients with hepatitis C. During her distinguished career, she has received numerous awards for research and teaching.
Jenny Heathcote, Toronto Western Hospital, Canada.
Wow! eBook
